GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Total Long-Term Assets

Hybio Pharmaceutical Co (SZSE:300199) Total Long-Term Assets : ¥2,569.6 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Hybio Pharmaceutical Co's Total Long-Term Assets for the quarter that ended in Mar. 2024 was ¥2,569.6 Mil.

Hybio Pharmaceutical Co Total Long-Term Assets Historical Data

The historical data trend for Hybio Pharmaceutical Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hybio Pharmaceutical Co Total Long-Term Assets Chart

Hybio Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,831.96 2,994.78 2,751.32 2,798.91 2,593.56

Hybio Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,785.32 2,788.26 2,730.02 2,593.56 2,569.61

Hybio Pharmaceutical Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Hybio Pharmaceutical Co Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Hybio Pharmaceutical Co (SZSE:300199) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Total Long-Term Assets
Comparable Companies
SZSE:002737 SZSE:002675 SZSE:002317 SHSE:600420 SZSE:300026 SHSE:600422 SZSE:002773 SZSE:300363 SZSE:002399 SZSE:300723 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Website
http://www.hybio.com.cn
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.

Hybio Pharmaceutical Co (SZSE:300199) Headlines

No Headlines